A Dose of Reality with Charles Spence17 Maalis 2025

Victor Paulus, SVP Regulatory Affairs at ARTBIO - Lutathera Approval and Lessons, Falling from Trees, ARTBIO's Culture

In this episode, I talked with Victor Paulus, Senior Vice President and Head of Regulatory Affairs at ARTBIO, where he shares his journey in the life sciences industry, discussing his career journey, challenges faced in regulatory affairs, and the unique culture at ARTBIO. He emphasizes the importance of collaboration, mentorship, and understanding the regulatory landscape to achieve success in drug development. Victor also provides valuable insights into industry observations and offers career advice for those starting in the field.

Here's what you're in:

What made Victor get into life science and what attracted him to regulatory affairs?
The challenges faced and approval of Lutathera.
Why regulatory professionals should be involved early in the development process?

Timestamps:

01:40 Victor's Early Career Journey

06:04 Career Highlights: The Approval of Lutathera

10:25 Challenges in Regulatory Affairs: The CMC Vaccine Program

18:58 The Culture and Vision at ARTBIO

25:07 Industry Observations and Common Mistakes

30:56 Career Advice for New Professionals

About Victor

Victor Paulus is the Senior Vice President and Head of Regulatory Affairs of ARTBIO, a clinical-stage radiopharmaceutical biotechnology. Prior to ARTBIO, he served as Senior Vice President of Regulatory Affairs for two years at Fusion Pharmaceuticals and also worked at AAA during the Lutathera approval. He has also worked on approvals including FluZone, Ze-mere-ra ,Pedia-rix, Anthim, Annovera, and Lutathera. Outside of his professional life, he has been passionate about environmental pursuits and enjoys activities such as birding, hiking, and spending time in the woods.

Connect with Victor

LinkedIn: https://www.linkedin.com/in/victor-paulus-25994a3/

Company Website: https://artbio.com/

About me

My name is Charles Spence and I lead Discera. After many years working in the life-science recruitment world, I decided to work for myself. Before doing recruitment I graduated with a biomedical degree, have worked in hospitals (including translation work in Seoul, South Korea), and also spent a year working in diabetes research in Stockholm. After doing research and travel, a career in business and science felt the most appropriate.

In 2023, I decided to launch my firm - Discera Search. A firm committed to solving the biggest talent needs of early clinical stage SME biotechs on the East Coast and DACH.

Connect with me:

LinkedIn:https://www.linkedin.com/in/charles-spence-clinical/

Website: https://www.discera-search.com/

Opinions and comments expressed by the guest do not represent the company and are fully their own.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(71)

Tobias Kampfenkel, MD, MHBA, Vice President of Early Clinical Development and Translational Research at Miltenyi Biomedicine, on Transformative Drugs in Oncology and Autoimmunity: It's Always the Team!

In this episode, I talked with Dr. Tobias Kampfenkel, Vice President of Early Clinical Development and Translational Research at Miltenyi Biomedicine. Tobias spent nearly a decade at Janssen building ...

15 Kesä 39min

Sofia Heigis, CEO of OncoPeptides, From Sales Rep to CEO, Being "Present", and Hiring for Self-Insight

In this episode, I talked with Sofia Heigis, Chief Executive Officer of OncoPeptides, about a career path that did not start where she expected. Sofia originally wanted to move into clinical operation...

31 Touko 38min

Jens Lindberg, CEO at Medivir, on The Biotech Rollercoaster - Medivir´s Previous Four Months (and Biotech Today in 2026)

In this episode, I talked with Jens Lindberg, CEO of Medivir AB, a Swedish biotech developing innovative therapies in liver cancer and rare disease. Jens brings over 30 years of late-stage development...

18 Touko 33min

Hubert Truebel, Managing Director at DEBRA Research, on Creating Own Career Opportunities...and a Practical Approach to Longevity

In this episode, I talked with Hubert Truebel, Managing Director at DEBRA Research, to discover a career that wasn’t built traditionally—but through creating opportunities where none formally existed....

4 Touko 28min

Sampreet Ramachandra, Head of Hematology Business Unit at Novartis Germany, on Launching Without a Playbook, Hiring Mistakes, and Leading with Equity

In this episode, I talked with Sampreet Ramachandra, Head of the Hematology Business Unit at Novartis Germany, about what it really takes to lead high-stakes launches — and what leadership looks like ...

30 Maalis 42min

Volker Wacheck, SVP at Taiho Oncology in Speaking Up, Asking vs. Accusing and Why Culture is So Important

In this episode, I talked with Volker Wacheck, SVP & Head of Clinical Development at Taiho Oncology, where he shared how a PI role in Vienna led him into industry, and why the hardest part wasn’t leav...

9 Maalis 29min

Dena Grayson, MD, PhD, SVP Clinical Development & Medical Affairs at Kyverna Therapeutics on Media Training, Communication within Biotech, and Dealing with Fake CVs

In this episode, I talked with Dr. Dena Grayson, a physician–scientist with over two decades in biotech drug development. At the time of this recording, she was SVP and Head of Clinical Development at...

24 Helmi 31min

Richard Nkulikiyinka, Chief Medical Officer at Antag Therapeutics, on Career Pivots, Trust and Why Leadership Is Never Linear

In this episode, I talked with Richard Nkulikiyinka, Chief Medical Officer at Antag Therapeutics, a Copenhagen-based biotech developing GIPR antagonists in the obesity space.Richard’s career began in ...

26 Tammi 35min